Related Experiment Video
Updated: Jun 12, 2025

Scanning Electron Microscopy of Macerated Tissue to Visualize the Extracellular Matrix
Published on: June 14, 2016
Myocardial Scarring and Sudden Cardiac Death in Young Patients With Hypertrophic Cardiomyopathy: A Multicenter Cohort
Raymond H Chan1, Laurine van der Wal2, Gabriela Liberato3
1Peter Munk Cardiac Centre, Toronto General Hospital, University Health Network, Toronto, Ontario, Canada.
Insights
Late gadolinium enhancement (LGE) on cardiovascular magnetic resonance (CMR) imaging predicts sudden cardiac death (SCD) in children and adolescents with hypertrophic cardiomyopathy (HCM). This finding improves risk stratification for these young patients.
Area of Science:
- Cardiology
- Medical Imaging
- Pediatrics
Background:
- Predicting sudden cardiac death (SCD) in pediatric hypertrophic cardiomyopathy (HCM) remains challenging.
- Late gadolinium enhancement (LGE) on cardiovascular magnetic resonance (CMR) imaging is linked to SCD in adult HCM patients.
Purpose of the Study:
- To assess the prognostic value of LGE in predicting SCD in patients under 21 years with HCM.
- To determine if LGE improves existing risk stratification models for pediatric HCM.
Main Methods:
- A multicenter, retrospective cohort study involving 700 patients (<21 years) with HCM who underwent CMR.
- Follow-up for SCD and surrogate events, with LGE presence and burden quantified.
- Kaplan-Meier and Cox proportional hazards models were used for analysis.
Main Results:
- LGE was present in 32.9% of patients and associated with a higher risk of SCD.
- A higher LGE burden (≥10%) significantly increased SCD risk (HR, 2.19).
- Incorporating LGE burden improved the predictive performance of established risk scores like HCM Risk-Kids and Precision Medicine in Cardiomyopathy.
Conclusions:
- Quantitative LGE is a significant risk factor for SCD in pediatric HCM patients.
- LGE assessment enhances the accuracy of risk stratification for young individuals with HCM.
- This highlights the importance of LGE in managing pediatric HCM and preventing SCD.
Importance:
The ability to predict sudden cardiac death (SCD) in children and adolescents with hypertrophic cardiomyopathy (HCM) is currently inadequate. Late gadolinium enhancement (LGE) by cardiovascular magnetic resonance (CMR) imaging is associated with SCD events in adults with HCM.
Objective:
To examine the prognostic significance of LGE in patients with HCM who are younger than 21 years.
Design, Setting, And Participants:
This multicenter, retrospective cohort study was conducted from April 8, 2015, to September 12, 2022, in patients with HCM who were younger than 21 years and had undergone CMR imaging across multiple sites in the US, Europe, and South America. Observers of CMR studies were masked toward outcomes and demographic characteristics.
Exposure:
Natural history of HCM.
Main Outcome And Measures:
The primary outcome was SCD and surrogate events, including resuscitated cardiac arrest and appropriate discharges from an implantable defibrillator. Continuous and categorical data are expressed as mean (SD), median (IQR), or number (percentage), respectively. Survivor curves comparing patients with and without LGE were constructed by the Kaplan-Meier method, and likelihood of subsequent clinical events was further evaluated using univariate and multivariable Cox proportional hazards models.
Results:
Among 700 patients from 37 international centers, median (IQR) age was 14.8 (11.9-17.4) years, and 518 participants (74.0%) were male. During a median (IQR) [range] follow-up period of 1.9 (0.5-4.1) [0.1-14.8] years, 35 patients (5.0%) experienced SCD or equivalent events. LGE was present in 230 patients (32.9%), which constituted an mean (SD) burden of 5.9% (7.3%) of left ventricular myocardium. The LGE amount was higher in older patients and those with greater left ventricular mass and maximal wall thickness; patients with LGE had lower left ventricular ejection fractions and larger left atrial diameters. The presence and burden of LGE was associated with SCD, even after correcting for existing risk stratification tools. Patients with 10% or more LGE, relative to total myocardium, had a higher risk of SCD (unadjusted hazard ratio [HR], 2.19; 95% CI, 1.59-3.02; P < .001). Furthermore, the addition of LGE burden improved the performance of the HCM Risk-Kids score (before LGE addition: 0.66; 95% CI, 0.58-0.75; after LGE addition: 0.73; 95% CI, 0.66-0.81) and Precision Medicine in Cardiomyopathy score (before LGE addition: 0.68; 95% CI, 0.49-0.77; after LGE addition: 0.73; 95% CI, 0.64-0.82) SCD predictive models.
Conclusions And Relevance:
In this retrospective cohort study, quantitative LGE was a risk factor for SCD in patients younger than 21 years with HCM and improved risk stratification.
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Rheumatic Heart Disease I: Introduction
Cardiomyopathy I: Introduction and Classification
Cardiomyopathy V: Interprofessional Care
Cardiomyopathy II: Dilated Cardiomyopathy
Myocarditis I: Introduction

